Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tc 99m glucarate

Drug Profile

Tc 99m glucarate

Alternative Names: AMISCAN; Tc-99m-glucarate; Technetium glucarate; Technetium Tc 99m glucarate

Latest Information Update: 03 Aug 2015

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Molecular Targeting Technologies
  • Developer DRAXIS Specialty Pharmaceuticals; Molecular Targeting Technologies
  • Class Organotechnetium compounds; Radiopharmaceutical diagnostics; Radiopharmaceuticals; Sugar acids; Technetium compounds
  • Mechanism of Action Single-photon emission-computed tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Acute coronary syndromes

Most Recent Events

  • 03 Aug 2015 No recent reports on development identified - Phase-II for Acute coronary syndromes (Diagnosis) in USA and Canada (IV)
  • 05 Jan 2005 DRAXIS Pharma has merged with DRAXIMAGE to form DRAXIS Specialty Pharmaceuticals
  • 25 Jul 2003 DRAXIMAGE and Bristol-Myers Squibb Imaging have extended and expanded their existing agreement in Canada
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top